磷苯妥英与左乙拉西坦预防幼儿意外或虐待性创伤性脑损伤后创伤后癫痫发作的有效性
该回顾性单中心队列纳入2011至2021年一家一级创伤中心收治的717例3岁以下创伤性脑损伤患儿(虐待性头部创伤263例、意外性创伤性脑损伤454例),其中135例(19%)接受磷苯妥英预防、152例(21%)接受左乙拉西坦预防、430例(60%)未接受任何癫痫预防。研究期间磷苯妥英预防使用减少(R2=0.67,p=0.004)、左乙拉西坦使用增加(R2=0.51,p=0.008),早期创伤后癫痫发作减少(R2=0.58,p=0.006)。虐待性头部创伤患儿较意外性创伤性脑损伤更常接受任何癫痫预防(52% vs. 27%;p<0.001)、更常住院期间发作≥1次(22% vs. 4%;p<0.001)。在控制年龄、入院年份、创伤性脑损伤机制和损伤严重程度后,两组癫痫发作发生无差异。
要点
- 3岁以下创伤性脑损伤患儿中,虐待性头部创伤较意外性创伤更常接受癫痫预防(52% vs. 27%;p<0.001),住院期间发作≥1次也更常见(22% vs. 4%;p<0.001)。
- 接受预防的患儿中,磷苯妥英组癫痫发作发生率高于左乙拉西坦组(33% vs. 18%;p=0.004),但控制年龄、入院年份、创伤机制和损伤严重程度后两组无差异。
- 研究期间磷苯妥英预防使用减少(R2=0.67,p=0.004)、左乙拉西坦使用增加(R2=0.51,p=0.008),早期创伤后癫痫发作减少(R2=0.58,p=0.006)。
- 作者认为,左乙拉西坦可能是该年龄组早期创伤后癫痫预防中与磷苯妥英同等有效的替代选择。
适用人群与场景
- 2011至2021年一家一级创伤中心收治的3岁以下创伤性脑损伤患儿,包括轻度(GCS 13-15)、中度(GCS 9-12)和重度(GCS 3-8)创伤性脑损伤,病因分为虐待性头部创伤与意外性创伤性脑损伤。
诊断标准与关键阈值
- 创伤性脑损伤严重程度按GCS评分划分:轻度GCS 13-15、中度GCS 9-12、重度GCS 3-8。
处置流程与药物剂量
- 抗癫痫药物由治疗医师酌情使用;135例(19%)接受磷苯妥英预防,152例(21%)接受左乙拉西坦预防,430例(60%)未接受任何癫痫预防。
研究设计与关键结果
- 回顾性单中心队列研究,纳入717例3岁以下创伤性脑损伤患儿(虐待性头部创伤263例、意外性创伤性脑损伤454例),其中135例(19%)接受磷苯妥英、152例(21%)接受左乙拉西坦、430例(60%)未接受任何癫痫预防。
- 研究期间磷苯妥英预防使用减少(R2=0.67,p=0.004),左乙拉西坦使用增加(R2=0.51,p=0.008),早期创伤后癫痫发作减少(R2=0.58,p=0.006)。
- 虐待性头部创伤患儿较意外性创伤性脑损伤更常接受任何癫痫预防(52% vs. 27%;p<0.001),住院期间发作≥1次更常见(22% vs. 4%;p<0.001)。
- 接受预防的患儿中,磷苯妥英组癫痫发作发生率高于左乙拉西坦组(33% vs. 18%;p=0.004)。
- 控制年龄、入院年份、创伤性脑损伤机制和损伤严重程度后,两组癫痫发作发生无差异。
证据类型、等级与局限
- 证据类型:回顾性单中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在3岁以下创伤性脑损伤患儿中,左乙拉西坦可能是早期创伤后癫痫预防中与磷苯妥英同等有效的替代选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Seizures occur frequently in pediatric patients with traumatic brain injury (TBI), particularly abusive head trauma (AHT). There are limited data on the effectiveness of fosphenytoin and levetiracetam to prevent posttraumatic seizures.
METHODS: We performed a retrospective single center cohort study of children < 3 years old admitted with mild [Glasgow Coma Scale (GCS) score 13-15], moderate (GCS 9-12), and severe (GCS 3-8) TBI at a level I trauma center from 2011 to 2021. Antiseizure medications were used at the discretion of the treating physicians. Nonparametric tests were used to compare antiseizure medication prophylaxis and TBI etiology.
RESULTS: A total of 717 patients (263 with AHT, 454 with accidental TBI) were included, of whom 135 (19%) received fosphenytoin, 152 (21%) received levetiracetam, and 430 (60%) did not receive any seizure prophylaxis. Over the study period, the use of fosphenytoin prophylaxis decreased (R2 = 0.67, p = 0.004), whereas the use of levetiracetam increased (R2 = 0.51, p = 0.008). Additionally, the occurrence of early posttraumatic seizures decreased (R2 = 0.58, p = 0.006). Children with AHT were more likely to receive any seizure prophylaxis than those with accidental TBI (52% vs. 27%; p < 0.001) and were more likely to have ≥ 1 seizure during hospitalization (22% vs. 4%; p < 0.001). Among children who received seizure prophylaxis, those who received fosphenytoin had a higher occurrence of seizures than those who received levetiracetam (33% vs.18%; p = 0.004). After controlling for age, admission year, TBI mechanism, and severity of injury, we observed no differences in seizure occurrence between groups.
CONCLUSIONS: In children < 3 years old with TBI, no differences were observed in occurrence of seizures between patients who received fosphenytoin and patients who received levetiracetam prophylaxis after controlling for patient factors including severity of injury. Levetiracetam may be an equally effective alternative to fosphenytoin for seizure prophylaxis for early posttraumatic seizure prevention in this age group.
参考来源
- McNamara CR, Menchaca CI, Abel TJ, et al. Effectiveness of Fosphenytoin and Levetiracetam to Prevent Posttraumatic Seizures in Young Children with Accidental or Abusive Traumatic Brain Injury. Neurocrit Care. 2024. PMID: 39237847. doi:10.1007/s12028-024-02093-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。